CN Stock MarketDetailed Quotes

688068 Beijing Hotgen Biotech Co.,Ltd

Watchlist
  • 45.44
  • +0.32+0.71%
Noon Break Nov 27 11:29 CST
4.20BMarket Cap-62161P/E (TTM)

Beijing Hotgen Biotech Co.,Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Beijing Hotgen Biotech Co.,Ltd Q3 2024 Earnings Date

Currency：CNYOct 31, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
137.35M
--
+37.48%
EPS
--
0.03
--
--
Analyst Rating
Strong Buy

Nov 26, 2024

Beijing Hotgen Biotech Co.,Ltd Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2019/FY210.412M / 240.325M--
DatePeriodRevenue/EstimateEarnings Call
--2019/FY210.412M / 240.325M--

Beijing Hotgen Biotech Co.,Ltd Earnings Reports

  • Hejing Biotech: Beijing Hejing Biotechnology Co., Ltd. Report for the Third Quarter of 2024

    Oct 30 12:00 ET

  • Beijing Hejing Biotechnology Co., Ltd. Report for the Third Quarter of 2024

    Oct 30 12:00 ET

  • Beijing Hejing Biotechnology Co., Ltd. 2024 Semi-Annual Report

    Aug 29 12:00 ET

  • Summary of the 2024 semi-annual report of Beijing Hejing Biotechnology Co., Ltd.

    Aug 29 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 26, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data